Therefore, selective inhibition of SIRT1 by EX-527 might improve endotoxemia-related acute lung injury moderately via inhibition of mTOR, which suggests that selective SIRT1 inhibitors may have potential for the pharmacological treatment of inflammatory lung injury [28]. Here, SIRT1 is linked to serum lipopolysaccharide activity.